These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35833585)

  • 1. Docetaxel in combination with metformin enhances antitumour efficacy in metastatic breast carcinoma models: a promising cancer targeting based on PEGylated liposomes.
    Vakili-Ghartavol R; Mehrabian A; Mirzavi F; Rezayat SM; Mashreghi M; Farhoudi L; Kharrazi S; Sadri K; Jaafari MR
    J Pharm Pharmacol; 2022 Sep; 74(9):1307-1319. PubMed ID: 35833585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of Docetaxel Loading Conditions in Liposomes: proposing potential products for metastatic breast carcinoma chemotherapy.
    Vakili-Ghartavol R; Rezayat SM; Faridi-Majidi R; Sadri K; Jaafari MR
    Sci Rep; 2020 Mar; 10(1):5569. PubMed ID: 32221371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Phase Transition Temperature on Therapeutic Efficacy of Liposomal Bortezomib.
    Korani M; Nikoofal-Sahlabadi S; Nikpoor AR; Ghaffari S; Attar H; Mashreghi M; Jaafari MR
    Anticancer Agents Med Chem; 2020; 20(6):700-708. PubMed ID: 31893998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialic acid-decorated liposomes enhance the anti-cancer efficacy of docetaxel in tumor-associated macrophages.
    Tran NP; Tran P; Yoo SY; Tangchang W; Lee S; Lee JY; Son HY; Park JS
    Biomater Adv; 2023 Nov; 154():213606. PubMed ID: 37678087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment responsive VEGF-antibody functionalized pH sensitive liposomes of docetaxel for augmented breast cancer therapy.
    Jain S; Deore SV; Ghadi R; Chaudhari D; Kuche K; Katiyar SS
    Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111832. PubMed ID: 33579470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel pegylated liposomal formulation of docetaxel with 3-n-pentadecylphenol derivative for cancer therapy.
    Zawilska P; Machowska M; Wisniewski K; Grynkiewicz G; Hrynyk R; Rzepecki R; Gubernator J
    Eur J Pharm Sci; 2021 Aug; 163():105838. PubMed ID: 33845119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-interactive mPEG-
    Gong F; Wang R; Zhu Z; Duan J; Teng X; Cui ZK
    Drug Deliv; 2020 Dec; 27(1):238-247. PubMed ID: 32003299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel-loaded liposomes: The effect of lipid composition and purification on drug encapsulation and in vitro toxicity.
    Pereira S; Egbu R; Jannati G; Al-Jamal WT
    Int J Pharm; 2016 Nov; 514(1):150-159. PubMed ID: 27863659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of phospholipids with high transition temperature to enhance redox-sensitive liposomal doxorubicin efficacy in colon carcinoma model.
    Mirhadi E; Askarizadeh A; Farhoudi L; Mashreghi M; Behboodifar S; Alavizadeh SH; Arabi L; Jaafari MR
    Chem Phys Lipids; 2024 Jul; 261():105396. PubMed ID: 38621603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved therapeutic index of the liposomal docetaxel-glutathione prepared by active click loading.
    Jin X; Zhou Q; Cao L; Tie X; Ouyang H; Pan X; Diao J; Zhu Y; Li Y; Liu X; Zheng Y
    Eur J Pharm Biopharm; 2024 Oct; 203():114435. PubMed ID: 39103002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docetaxel encapsulation in nanoscale assembly micelles of folate-PEG-docetaxel conjugates for targeted fighting against metastatic breast cancer in vitro and in vivo.
    Andisheh F; Oroojalian F; Shakour N; Ramezani M; Shamsara J; Khodaverdi E; Nassirli H; Hadizadeh F; Alibolandi M
    Int J Pharm; 2021 Aug; 605():120822. PubMed ID: 34182039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
    Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
    J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GE11 peptide-conjugated nanoliposomes to enhance the combinational therapeutic efficacy of docetaxel and siRNA in laryngeal cancers.
    Xu WW; Liu DY; Cao YC; Wang XY
    Int J Nanomedicine; 2017; 12():6461-6470. PubMed ID: 28919747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate-conjugated liposomal docetaxel reverses multidrug resistance in breast cancer cells.
    Li N; Fu T; Fei W; Han T; Gu X; Hou Y; Liu Y; Yang J
    J Pharm Pharmacol; 2019 Aug; 71(8):1243-1254. PubMed ID: 31215039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor Effects of Docetaxel in Truncated Basic Fibroblast Growth Factor- Functionalized Liposomes Delivered by d-α-tocopheryl Polyethylene Glycol 2000 Succinate.
    Wen J; Wang Z; Qiu N; Liu H; Shu X; Zhu Z; Bai P; Yang L; Chen L
    Curr Pharm Des; 2020; 26(34):4338-4348. PubMed ID: 32324508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy.
    Bathara M; Date T; Chaudhari D; Ghadi R; Kuche K; Jain S
    Mol Pharm; 2020 Jul; 17(7):2473-2486. PubMed ID: 32496783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing the therapeutic efficacy of cisplatin PEGylated liposomes via incorporation of different DPPG ratios: In vitro and in vivo studies.
    Marzban E; Alavizadeh SH; Ghiadi M; Khoshangosht M; Khashayarmanesh Z; Abbasi A; Jaafari MR
    Colloids Surf B Biointerfaces; 2015 Dec; 136():885-91. PubMed ID: 26547316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How docetaxel entrapment, vesicle size, zeta potential and stability change with liposome composition-A formulation screening study.
    Holsæter AM; Wizgird K; Karlsen I; Hemmingsen JF; Brandl M; Škalko-Basnet N
    Eur J Pharm Sci; 2022 Oct; 177():106267. PubMed ID: 35872073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma.
    Nik ME; Malaekeh-Nikouei B; Amin M; Hatamipour M; Teymouri M; Sadeghnia HR; Iranshahi M; Jaafari MR
    Sci Rep; 2019 Jul; 9(1):9527. PubMed ID: 31267009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is an alternative drug delivery system needed for docetaxel? The role of controlling epimerization in formulations and beyond.
    Manjappa AS; Goel PN; Vekataraju MP; Rajesh KS; Makwana K; Ukawala M; Nikam Y; Gude RP; Murthy RS
    Pharm Res; 2013 Oct; 30(10):2675-93. PubMed ID: 23756759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.